Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis.

In terms of lung pathology, both α-IL-1β and ceftazidime treated animals demonstrated diminished pulmonary inflammation and abscess formation at 72 h postinfection compared with controls ( P <0.01) although this difference did not reach statistical significance for the α-IL-1β group (Fig. 4 C; Fig.

also in 111,027 other papers